By: Dr. Laura Kuhlmann, ORT Times Science Writer
The latest advances in cancer research have led to novel therapies and improved screening programs, increasing the overall cancer survival rate. However, cancer disproportionately affects Canadians over the age of 50. This demographic is unfortunately underrepresented in clinical trials and less information is available about treatments benefitting seniors. Furthermore, older adults represent more complex cases due to chronic illness, multiple medication treatment, cognitive impairments and other vulnerabilities. It is not always known if aggressive cancer treatment is feasible for these patients. There is therefore a need to identify opportunities for further prevention and cancer control for the elderly.
One of the first steps to improving cancer care for older adults is to recognize the genetic and metabolic characteristics of tumours arising in this age group. DNA mutations accumulated from repeated cell divisions, as our bodies mature and heal, and exposure to cancer-promoting substances (carcinogens) are the main reasons for the increased prevalence of cancer in old age. Many prevention programs have raised awareness over exposure to external carcinogens, such as cigarette smoke, alcohol and ultraviolet radiation, in an effort to inform the public to take preventive measures and reduce their overall risk of developing cancer. Research has also focused on detecting cancer-promoting substances produced by our own metabolism that can accumulate with age. For example, a recent paper published in the journal Nature reported that a by-product of protein and fat digestion called methylmalonic acid (MMA), accumulates in the blood with age and may promote the spread of cancer cells from the primary tumour to distant organs. The molecule appears to be important for cancer spread, not cancer initiation, based on the observation that people with high blood MMA levels were cancer free. Such research is valuable for identifying how cancer starts and spreads in seniors and may uncover new ways to treat older adults.
Another way to improve cancer care for seniors is to identify their special needs and vulnerabilities beyond the medical aspects of care. Geriatric assessments should be employed prior to determining an individual’s tolerance of therapy and appraising the risks and benefits of treatment.
The University Health Network aims to advance senior oncology treatment and patient outcomes through educational programs such as the Geriatric Oncology Program at the Princess Margaret Cancer Centre. Additional opportunities to address seniors’ needs are available at the Older Adults with Cancer Clinic (OACC) at the Princess Margaret Cancer Centre, where a team of specialized professionals provides personalized care plans for vulnerable patients.
As one in two Canadians is predicted to be afflicted by cancer during their lifetime, it is therefore important to expand our knowledge of geriatric cancer, while educating clinicians, patients and their families on how to address the complexities of cancer treatment in seniors. Patients and families searching for additional information can contact OACC